Hanmi's new amlodipine salt to get patent approval first in Korea.

The patent for amlodpine camsylate, a new salt of amlodpine and anti-hypertension drug, (brand name: Amodipine) has been approved for the first time in Korea under the patent registration No. 0452491.

Amlodpine camsylate will be the first rival anti-hypertension drug against Norvasc, its original brand, producing only by Hanmi in Korea.

5 amlodpine generics are launched in the local mark...